1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Companion Diagnostic Market Size Growth Rate by Type (2020-2025)
1.3.2 Assay Kits
1.3.3 Reagents
1.4 Market Segment by Application
1.4.1 Global Companion Diagnostic Market Share by Application (2020-2025)
1.4.2 Pharmaceutical & Biopharmaceutical Companies
1.4.3 Laboratories
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Companion Diagnostic Production Value 2015-2025
2.1.2 Global Companion Diagnostic Production 2015-2025
2.1.3 Global Companion Diagnostic Capacity 2015-2025
2.1.4 Global Companion Diagnostic Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Companion Diagnostic Market Size CAGR of Key Regions
2.2.2 Global Companion Diagnostic Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Companion Diagnostic Capacity by Manufacturers
3.1.2 Global Companion Diagnostic Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Companion Diagnostic Revenue by Manufacturers (2015-2019)
3.2.2 Companion Diagnostic Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.3 Companion Diagnostic Price by Manufacturers
3.4 Key Manufacturers Companion Diagnostic Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Companion Diagnostic Market
3.6 Key Manufacturers Companion Diagnostic Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Assay Kits Production and Production Value (2015-2019)
4.1.2 Reagents Production and Production Value (2015-2019)
4.2 Global Companion Diagnostic Production Market Share by Type
4.3 Global Companion Diagnostic Production Value Market Share by Type
4.4 Companion Diagnostic Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Companion Diagnostic Consumption by Application
6 Production by Regions
6.1 Global Companion Diagnostic Production (History Data) by Regions 2015-2019
6.2 Global Companion Diagnostic Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Companion Diagnostic Production Growth Rate 2015-2019
6.3.2 United States Companion Diagnostic Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Companion Diagnostic Import & Export
6.4 European Union
6.4.1 European Union Companion Diagnostic Production Growth Rate 2015-2019
6.4.2 European Union Companion Diagnostic Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Companion Diagnostic Import & Export
6.5 China
6.5.1 China Companion Diagnostic Production Growth Rate 2015-2019
6.5.2 China Companion Diagnostic Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Companion Diagnostic Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Companion Diagnostic Consumption by Regions
7.1 Global Companion Diagnostic Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Companion Diagnostic Consumption by Type
7.2.2 United States Companion Diagnostic Consumption by Application
7.3 European Union
7.3.1 European Union Companion Diagnostic Consumption by Type
7.3.2 European Union Companion Diagnostic Consumption by Application
7.4 China
7.4.1 China Companion Diagnostic Consumption by Type
7.4.2 China Companion Diagnostic Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Companion Diagnostic Consumption by Type
7.5.2 Rest of World Companion Diagnostic Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Companion Diagnostic
8.1.4 Companion Diagnostic Product Introduction
8.1.5 Abbott Laboratories Recent Development
8.2 Agilent Technologies
8.2.1 Agilent Technologies Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Companion Diagnostic
8.2.4 Companion Diagnostic Product Introduction
8.2.5 Agilent Technologies Recent Development
8.3 Danaher Corporation
8.3.1 Danaher Corporation Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Companion Diagnostic
8.3.4 Companion Diagnostic Product Introduction
8.3.5 Danaher Corporation Recent Development
8.4 Illumina
8.4.1 Illumina Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Companion Diagnostic
8.4.4 Companion Diagnostic Product Introduction
8.4.5 Illumina Recent Development
8.5 Myriad Genetics
8.5.1 Myriad Genetics Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Companion Diagnostic
8.5.4 Companion Diagnostic Product Introduction
8.5.5 Myriad Genetics Recent Development
8.6 Qiagen
8.6.1 Qiagen Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Companion Diagnostic
8.6.4 Companion Diagnostic Product Introduction
8.6.5 Qiagen Recent Development
8.7 Roche
8.7.1 Roche Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Companion Diagnostic
8.7.4 Companion Diagnostic Product Introduction
8.7.5 Roche Recent Development
8.8 Thermo Fisher Scientific
8.8.1 Thermo Fisher Scientific Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Companion Diagnostic
8.8.4 Companion Diagnostic Product Introduction
8.8.5 Thermo Fisher Scientific Recent Development
8.9 Sysmex Corporation
8.9.1 Sysmex Corporation Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Companion Diagnostic
8.9.4 Companion Diagnostic Product Introduction
8.9.5 Sysmex Corporation Recent Development
8.10 Novartis
8.10.1 Novartis Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Companion Diagnostic
8.10.4 Companion Diagnostic Product Introduction
8.10.5 Novartis Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Companion Diagnostic Capacity, Production Forecast 2020-2025
9.1.2 Global Companion Diagnostic Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Companion Diagnostic Production and Value Forecast by Regions 2020-2025
9.2.2 Global Companion Diagnostic Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Companion Diagnostic Production Forecast by Type
9.7.2 Global Companion Diagnostic Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Companion Diagnostic Sales Channels
10.2.2 Companion Diagnostic Distributors
10.3 Companion Diagnostic Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
